Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 24, 2018
Patent Application Number
14666117
Date Filed
March 23, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
Rivastigmine transdermal compositions are provided. Aspects of the transdermal compositions include an active agent layer which includes rivastigmine and a solubility modulator, e.g., crosslinked acrylic acid polymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
